Common peak approach using mass spectrometry data sets for predicting the effects of anticancer drugs on breast cancer

Cancer Informatics

Volumn 3, Issue , 2007, Pages 285-293

  Ushijima, Masaru ^a   Miyata, Satoshi ^a   Eguchi, Shinto ^d   Kawakita, Masanori ^e   Yoshimoto, Masataka ^f   Iwase, Takuji ^c   Akiyama, Futoshi ^b   Sakamoto, Goi ^b   Nagasaki, Koichi ^a   Miki, Yoshio ^a,b   Noda, Tetsuo ^a,b   Hoshikawa, Yutaka ^a,b   Matsuura, Masaaki ^a,b  

^a CANCER CHEMOTHERAPY CENTER   (Japan)

^b CANCER INSTITUTE   (Japan)

^c CANCER INSTITUTE HOSPITAL   (Japan)

^d INSTITUTE OF STATISTICAL MATHEMATICS   (Japan)

^e KYUSHU UNIVERSITY   (Japan)

^f International University of Health and Welfare Mita Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL;

ALGORITHM; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; HUMAN; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; VALIDATION PROCESS; CANCER PATIENT; COMMON PEAK APPROACH; COMPARATIVE STUDY; DATA PROCESSING; DRUG EFFECT; DRUG RESPONSE; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; MEASUREMENT ACCURACY; NEOADJUVANT CHEMOTHERAPY; PREDICTIVE VALUE; STATISTICAL ANALYSIS; VALIDATION STUDY;

EID: 49649107415     PISSN: 11769351     EISSN: 11769351     Source Type: Journal    
DOI: 10.1177/117693510700300029     Document Type: Article

References (24)

1. Baggerly, K.A., Morris, J.S. and Coombes, K.R. 2004. Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments. Bioinformatics, 20:777-85.
2. Batorfi, J., Ye, B., Mok, S.C. et al. 2003. Protein profiling of complete mole and normal placenta using ProteinChip analysis on laser capture microdissected cells. Gynecol. Oncol., 88:424-8.
3. Conrads, T.P., Fusaro, V.A., Ross, S. et al. 2004. High-resolution serum proteomic features for ovarian cancer detection. Endocr. Relat. Cancer, 11:163-78
4. Freund, Y. and Schapire, R.E. 1997. A decision-theoretic generalization of on-line learning and an appplication to boosting. J. Comp. Sys. Sci., 55:119-139.
5. Fung, E.T. and Enderwick, C. 2002. ProteinChip clinical proteomics: computational challenges and solutions. Biotechniques, 32(Suppl):34-41.
6. Fushiki, T., Fujisawa H. and Eguchi S. 2006. Identification of biomarkers from mass spectrometry data using a "common" peak approach. BMC Bioinformatics, 7:358.
7. Geurts P., Fillet, M., de Seny, D. et al. 2005. Proteomic mass spectra classification using decision tree based ensemble methods. Bioinformatics, 21:3138-45.
8. Guyon, I., Weston, J., Barnhill, S. et al. 2002. Gene selection for cancer classification using support vector machines. Machine Learning, 46:389-422.
9. Hastie, T., Tibshirani, R. and Friedman, J. 2001. The Elements of Statistical Learning: Data Mining, Inference and Prediction. New York: Springer.
10. Krieg, R.C., Gaisa, N.T., Paweletz, C.P. et al. 2005. Proteomic analysis of human bladder tissue using SELDI approach following microdissection techniques. Methods Mol. Biol., 293:255-67.
11. Lin, S.M., Haney, R.P., Campa, M.J. et al. 2005. Characterising phase variations in MALDI-TOF data and correcting them by peak alignment. Cancer Informatics, 1:32-40.
12. Lyons-Weiler, J., Pelikan, R., Zeh, H.J. et al. 2005. Assessing the statistical significance of the achieved classification error of classifiers constructed using serum peptide profiles, and a prescription for random sampling repeated studies for massive high-throughput genomic and proteomic studies. Cancer Informatics, 1:53-77.
13. Meleth, S., Eltoum, I.E., Zhu, L. et al. 2005. Novel approaches to smoothing and comparing SELDI TOF spectra. Cancer Informatics, 1:78-85.
14. Murata, N., Takenouchi, T., Kanamori, T. et al. 2004. Information geometry of U-Boost and Bregman divergence. Neural Computation, 16:1437-1481.
15. Petricoin, E.F. III., Ardekani, A.M., Hitt, B.A. et al. 2002. Use of proteomic patterns in serum to identify ovarian cancer. Lancet, 359:572-7.
16. Pusztai, L., Gregory, B.W., Baggerly, K.A. et al. 2004. Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma. Cancer, 100:1814-22.
17. Qu, Y., Adam, B.L., Thornquist, M. et al. 2003. Data reduction using a discrete wavelet transform in discriminant analysis of very high dimensionality data. Biometrics, 59:143-51.
18. The Japanese Breast Cancer Society. 2005. General rules for clinical and pathological recording of breast cancer 2005. Breast Cancer: J. Jpn. Breast Cancer Soc., 12:Supplement.
19. Tibshirani, R., Hastie, T., Narasimhan, B. et al. 2004. Sample classification from protein mass spectrometry, by 'peak probability contrasts' Bioinformatics, 20:3034-44.
20. Verma, M., Wright Jr, G.L., Hanash, S.M. et al. 2001. Proteomic approaches within the NCI early detection research network for the discovery and identification of cancer biomarkers. Ann. N. Y. Acad. Sci., 945:103-15.
21. Wong, J.W.T., Cagney, G. and Cartwright, H.M. 2005. SpecAlign-processing and alignment of mass spectra datasets. Bioinformatics, 21:2088-90.
22. Wulfkuhle, J.D., Paweletz, C.P., Steeg, P.S. et al. 2003. Proteomic approaches to the diagnosis, treatment, and monitoring of cancer. Adv. Exp. Med. Biol., 532:59-68.
23. Yasui, Y., Pepe, M., Thompson, M.L. et al. 2003. A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection. Biostatistics, 4:449-63.
24. Yu, J.S., Ongarello, S., Fiedler, R. et al. 2005. Ovarian cancer identification based on dimensionality reduction for high-throughput mass spectrometry data. Bioinformatics, 21:2200-9.